1
|
Loison R, Abbar B, Drouin L, Bonnet-Bensimon C, Cuvier C, Giacchetti S, Espie M, Teixeira L, De Castelbajac V. Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study. Acta Oncol 2023; 62:1961-1966. [PMID: 37750392 DOI: 10.1080/0284186x.2023.2260943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Accepted: 09/14/2023] [Indexed: 09/27/2023]
Affiliation(s)
- Rebecca Loison
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Baptiste Abbar
- Sorbonne Université, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie, CLIP² Galilée, Paris, France
| | - Leonor Drouin
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Charlotte Bonnet-Bensimon
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Caroline Cuvier
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Sylvie Giacchetti
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Marc Espie
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Luis Teixeira
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| | - Victoire De Castelbajac
- Université de Paris Cité, INSERM U976, Assistance Publique-Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Breast Disease Unit (Sénopole), Paris, France
| |
Collapse
|
2
|
Hours A, Toussaint A, De Castelbajac V, Sautter C, Borghese J, Frank S, Coussy F, Laas E, Grandal B, Dumas E, Daoud E, Guerin J, Balezeau T, Feron JG, Fourchotte V, Kirova Y, Lerebours F, Pierga JY, Guillot E, Santulli P, Grynberg M, Sonigo C, Reyrat E, Soibinet-Oudot P, Reyal F, Hamy AS. Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy. Front Oncol 2021; 11:701620. [PMID: 34650912 PMCID: PMC8507557 DOI: 10.3389/fonc.2021.701620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 08/31/2021] [Indexed: 11/13/2022] Open
Abstract
PURPOSE Female breast cancer (BC) patients exposed to gonadotoxic chemotherapy are at risk of future infertility. There is evidence of disparities in the discussion of fertility preservation for these patients. The aim of the study was to identify factors influencing the discussion of fertility preservation (FP). MATERIAL AND METHODS We analyzed consecutive BC patients treated by chemotherapy at Institut Curie from 2011-2017 and aged 18-43 years at BC diagnosis. The discussion of FP was classified in a binary manner (discussion/no discussion), based on mentions present in the patient's electronic health record (EHR) before the initiation of chemotherapy. The associations between FP discussion and the characteristics of patients/tumors and healthcare practitioners were investigated by logistic regression analysis. RESULTS The median age of the 1357 patients included in the cohort was 38.7 years, and median tumor size was 30.3 mm. The distribution of BC subtypes was as follows: 702 luminal BCs (58%), 241 triple-negative breast cancers (TNBCs) (20%), 193 HER2+/HR+ (16%) and 81 HER2+/HR- (6%). All patients received chemotherapy in a neoadjuvant (n=611, 45%) or adjuvant (n= 744, 55%) setting. A discussion of FP was mentioned for 447 patients (33%). Earlier age at diagnosis (discussion: 34.4 years versus no discussion: 40.5 years), nulliparity (discussion: 62% versus no discussion: 38%), and year of BC diagnosis were the patient characteristics significantly associated with the mention of FP discussion. Surgeons and female physicians were the most likely to mention FP during the consultation before the initiation of chemotherapy (discussion: 22% and 21%, respectively). The likelihood of FP discussion increased significantly over time, from 15% in 2011 to 45% in 2017. After multivariate analysis, FP discussion was significantly associated with younger age, number of children before BC diagnosis, physicians' gender and physicians' specialty. CONCLUSION FP discussion rates are low and are influenced by patient and physician characteristics. There is therefore room for improvement in the promotion and systematization of FP discussion.
Collapse
Affiliation(s)
- Alice Hours
- Department of Surgery, Institut Curie, University Paris, Paris, France
| | - Aullene Toussaint
- Department of Surgery, Institut Curie, University Paris, Paris, France
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Victoire De Castelbajac
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
- Sénopole Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, University Paris, Paris, France
| | - Camille Sautter
- Department of Surgery, Institut Curie, University Paris, Paris, France
| | - Julie Borghese
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Sophie Frank
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
| | - Florence Coussy
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
| | - Enora Laas
- Department of Surgery, Institut Curie, University Paris, Paris, France
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
| | - Beatriz Grandal
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Elise Dumas
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Eric Daoud
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | | | | | | | | | - Youlia Kirova
- Department of Radiation Therapy, Institut Curie, Paris, France
| | - Florence Lerebours
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Jean-Yves Pierga
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Eugénie Guillot
- Department of Surgery, Institut Curie, University Paris, Paris, France
| | - Pietro Santulli
- Department of Obstetrics and Gynecology, Hôpital Cochin, University Paris, Paris, France
| | - Michael Grynberg
- Department of Reproductive Medicine and Fertility Preservation, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris Sud, Assistance Publique - Hôpitaux de Paris, Clamart, France
- Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Bondy, France
| | - Charlotte Sonigo
- Department of Reproductive Medicine and Fertility Preservation, Hôpital Antoine Béclère, Hôpitaux Universitaires Paris Sud, Assistance Publique - Hôpitaux de Paris, Clamart, France
| | - Emmanuel Reyrat
- Department of Data and Informatics, Unicancer, Paris, France
| | | | - Fabien Reyal
- Department of Surgery, Institut Curie, University Paris, Paris, France
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| | - Anne-Sophie Hamy
- Department of Surgery, Institut Curie, University Paris, Paris, France
- Department of Medical Oncology, Institut Curie, University Paris, Paris, France
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France
| |
Collapse
|
3
|
Labidi-Galy SI, De La Motte Rouge T, Derbel O, Kalbacher E, Wolfer A, Olivier T, Hu K, Tredan O, Guevara H, Bazan F, De Castelbajac V, Combes JD, Vaflard P, Crivelli L, Bonadona V, Viassolo V, Golmard L, Buisson A, Rodrigues M, Ray-Coquard IL. Predictive factors for prolonged response to olaparib as maintenance therapy in ovarian cancer patients with BRCA mutations. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.5558] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - Olfa Derbel
- Institut du Cancer Jean Mermoz, Lyon, France
| | | | - Anita Wolfer
- Multidisciplinary Center for Oncology (CePO), University Hospital CHUV, Lausanne, Switzerland
| | | | - Ketty Hu
- Universite de Geneve, Geneva, Switzerland
| | - Olivier Tredan
- Département d'Oncologie Médicale, Centre Léon Bérard, Lyon, France
| | | | - Fernando Bazan
- Institut Regional du Cancer en Franche-Comté - University Hospital, Besançon, France
| | | | | | - Pauline Vaflard
- Department of Medical Oncology, Institut Curie, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|